Interview: How Tragedy Changed the FDA

As an FDA advisory committee prepares to weigh whether specialized pharmacies should be allowed to dispense seven unapproved peptides, Mikkael A. Sekeres, a scientist and former adviser, discusses the history and nuances of FDA oversight, including its process for screening advisory committee members for conflicts of interest.

Source: Undark Magazine